SOCIETY FOR NEUROSCIENCE 2024
Event Date: October 6-9, 2024 | Venue: McCormick Place | Chicago, IL
Neurotechnology innovators and specialists will be available to discuss your research and share their insights.
Join us at Booth #280. We look forward to connecting with you.
NEUROMODULATION DEVICES
The neuroscience technologies listed below provide open access to collaborate with neuromodulation device innovators and/or product specialists with the goal of the researcher achieving their research modalities apart from us, ensuring that the researcher maximizes the utilization of the device.
• Brainwave Bulletin •
Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines
Simone Rossi, Andrea Antal, Sven Bestmann, Marom Bikson, Carmen Brewer, Jürgen Brockmöller, Linda L. Carpenter, Massimo Cincotta, Robert Chen, Jeff D. Daskalakis, Vincenzo Di Lazzaro, Michael D. Fox, Mark S. George, Donald Gilbert, Vasilios K. Kimiskidis, Giacomo Koch, Risto J. Ilmoniemi, Jean Pascal Lefaucheur, Letizia Leocani, Sarah H. Lisanby and Mark Hallett
TMS
Read MoreBulletin Archive
Neural Hub
Recent Development in TMS Therapy Systems with FDA Clearance
Transcranial Magnetic Stimulation (TMS) has evolved significantly since its introduction, with multiple FDA clearances affirming its growing role in treating mental health conditions, especially major depressive disorder (MDD). These advancements are backed by robust clinical trials and real-world data that validate the efficacy, safety, and increasing versatility of TMS therapy.
Transcranial Magnetic Stimulation (TMS) Devices: How Do They Differ?
Transcranial Magnetic Stimulation (TMS) is a non-invasive technique that uses magnetic fields to stimulate nerve cells in the brain. It has gained prominence in both clinical and research settings primarily for its therapeutic applications in neuropsychiatric disorders.
From Lab to Clinic: The Transformative Power of Transcranial Magnetic Stimulation (TMS) in Neuroscience
TMS was first introduced in 1985 by Dr. Anthony Barker and his colleagues, including Dr. Reza Jalinous, at the University of Sheffield. They developed a device capable of generating brief magnetic pulses, which could penetrate the scalp and skull to stimulate neurons in the brain. This breakthrough opened new avenues for investigating brain physiology and mapping cortical functions non-invasively.
About Us
Founded in 1991, Jali Medical has been a partner with researchers and clinicians throughout the history of non-invasive brain stimulation. Our extensive knowledge comes from our years of experience and collaborations with our partners and clients.
Jali Medical specializes in distributing cutting-edge neurotechnologies, including Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current/Electric Stimulation (tDCS/tES), Electroencephalography (EEG), Electromyography (EMG), neuronavigation systems, and cognitive, behavioral, and movement assessment research devices. For clinical use, we offer the FDA-cleared TMS Therapy Package System and the Visor2 neuronavigation system.
We are dedicated to providing our end-users with the highest quality neuroscience equipment and accessories. Our devices have been featured in hundreds of seminal research studies and are the preferred choice for prominent research and clinical institutions.
States & Territories
Institution With Our Devices
Clients
Years In Service
Our Clients
Connect with Us!
At Jali Medical, we believe in the power of collaboration and open dialogue. Whether you have questions, feedback, or are seeking innovative solutions, our team is eager to hear from you. Reach out today and let's start a conversation that matters.